RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 79.00
+0.75 (0.96%)
At close: Dec 12, 2025
RemeGen Market Cap
RemeGen has a market cap or net worth of 49.84 billion as of December 12, 2025. Its market cap has increased by 187.23% in one year.
Market Cap
49.84B
Enterprise Value
50.94B
Revenue
2.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
79.00
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 49.84B, an increase of 49.28%. That is a compound annual growth rate of 8.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 49.82B | 255.74% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | 46.53B | 39.37% |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 274.43B |
| Hansoh Pharmaceutical Group Company | 257.41B |
| JD Health International | 188.25B |
| Innovent Biologics | 143.10B |
| WuXi Biologics | 138.62B |
| Sino Biopharmaceutical | 121.03B |
| Akeso | 107.59B |
| Sichuan Kelun-Biotech Biopharmaceutical | 96.12B |